CRISPR Therapeutics AG (NASDAQ:CRSP)

67.42
Delayed Data
As of Nov 20
 -1.04 / -1.52%
Today’s Change
22.22
Today|||52-Week Range
74.00
+135.98%
Year-to-Date

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 80.00, with a high estimate of 107.00 and a low estimate of 28.00. The median estimate represents a +18.66% increase from the last price of 67.42.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.57
Sales
$41.4M
Reporting Date
Mar 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -123.61%
 
 
 
 
 
 
Growthannually 100.20%
 
 
 
 
 

Sales

Growthquarterly -80.44%
 
 
 
 
 
 
Growthannually 8,153.38%
 
 
 
 
 
Key to the earnings and sales forecast charts.